0001127602-16-054416.txt : 20160602
0001127602-16-054416.hdr.sgml : 20160602
20160602145648
ACCESSION NUMBER: 0001127602-16-054416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160531
FILED AS OF DATE: 20160602
DATE AS OF CHANGE: 20160602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioScrip, Inc.
CENTRAL INDEX KEY: 0001014739
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 050489664
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1600 BROADWAY
STREET 2: SUITE 950
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 720 697 5200
MAIL ADDRESS:
STREET 1: 1600 BROADWAY
STREET 2: SUITE 950
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: MIM CORP
DATE OF NAME CHANGE: 19960516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOLUBIAK MYRON Z
CENTRAL INDEX KEY: 0001199080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28740
FILM NUMBER: 161692234
MAIL ADDRESS:
STREET 1: C/O CITIUS PHARMACEUTICALS, INC.
STREET 2: 63 GREAT ROAD
CITY: MAYNARD
STATE: MA
ZIP: 01754
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-05-31
1
0001014739
BioScrip, Inc.
BIOS
0001199080
HOLUBIAK MYRON Z
C/O BIOSCRIP, INC.
1600 BROADWAY, SUITE 950
DENVER
CO
80202
1
Common Stock, $.0001 Par Value
2016-05-31
4
M
0
10000
0
A
50000
D
Common Stock, $.0001 Par Value
2016-05-31
4
D
0
10000
2.70
D
40000
D
Phantom Stock
2016-05-31
4
M
0
10000
D
Common Stock, $.0001 Par Value
10000
0
D
Under the terms of the market-based cash award, as publicly filed, each share of "phantom stock" is the economic equivalent of one share of the Issuer's common stock, par value $0.0001 per share ("Common Stock"). Each share of "phantom stock" granted pursuant to the market-based cash award was entitled to a cash payment equal to the fair market value of a share of Common Stock as of the vesting date, which was $2.70 based on the closing market price of the Common Stock on May 31, 2016.
The cash settlement of the market-based cash award is reported solely for purposes of Form 4 as the deemed disposition of the market-based cash award and a deemed simultaneous acquisition and disposition of 10,000 shares of Common Stock.
The market-based cash award vested on May 31, 2016, the business day immediately preceding the date of the Issuer's 2016 annual meeting of stockholders, because the reporting person served as a director of the Issuer as of such date. If unvested on the vesting date, the market-based cash award would have expired on May 31, 2016.
/s/ Myron Z. Holubiak
2016-06-02